The goal of this study is to identify physiologic and molecular mechanisms that underlie hypoglycemia in the absence of diabetes (or medications that can cause hypoglycemia) and to investigate potential genetic and microbiome differences which contribute to hypoglycemia. We will test the hypothesis that hypoglycemia in the absence of diabetes is linked to genetic variation or the microbiome, and identify whether additional medical history or diagnoses are enriched in the population of patients with hypoglycemia.
Protocol Amendment History
7 amendments
This ClinicalTrials.gov record has been amended 7 times since 2020-06-10; most recent amendment 2026-02-04.
Status change: Recruiting → Active, Not Recruiting2024-01-04